Novo Nordisk

Showing 15 posts of 188 posts found.

peter_henshaw

The Partners hires creative director from InVentive

June 30, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, Novo Nordisk, The International Aids Society, The partners, inventive, peter henshaw

Brand consultancy The Partners has appointed creative director Peter Henshaw to lead its creative offerings for the agency’s health team.  …

EMA image

EMA waves through a raft of drug recommendations

June 26, 2015
Research and Development, Sales and Marketing AbbVie, Alexion, CHMP, EMA, Novartis, Novo Nordisk, brett wells

The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency has recommended several treatments for marketing …

Novo image

Novo Nordisk launches diabetes combination

June 8, 2015
Sales and Marketing Novo Nordisk, Xutolphy, ada, diabetes

Diabetes specialist firm Novo Nordisk has launched a new treatment in the UK which combines two of the Danish firm’s …

screen_shot_2015-05-06_at_11

Lundbeck gains new chief executive from Novo Nordisk

May 6, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing KÃ¥re Schultz, Lundbeck, Novo Nordisk, Rebien Sorensen

Danish pharma giant Lundbeck has appointed KÃ¥re Schultz as its new president and chief executive. Schultz (pictured) will take up …

Novo image

Novo Nordisk invests in haemophilia with Denmark facility

May 5, 2015
Manufacturing and Production, Sales and Marketing Novo Nordisk, diabetes, haemophilia, novoseven

Novo Nordisk is spending around $225 million on a new facility in Kalundborg, Denmark to produce active pharmaceutical ingredients for haemophilia …

Novo image

Novo Nordisk obesity drug is launched in the US

April 23, 2015
Sales and Marketing Novo Nordisk, liraglutide, obesity, overweight, saxenda, world health organization

Novo Nordisk is rolling out its obesity drug Saxenda across the US for the treatment of obese adult patients. Saxanda …

Novo image

Novo Nordisk opens insulin plant in Russia

April 10, 2015
Manufacturing and Production, Sales and Marketing Novo Nordisk, Russia, diabetes, flexpen, insulin, kaluga, penfill

Denmark’s Novo Nordisk has opened a new manufacturing facility in Russia to produce more of its diabetes offerings in the …

Novo image

FDA to look again at Novo Nordisk insulin submissions

April 8, 2015
Research and Development, Sales and Marketing Novo Nordisk, Ryzodeg, Tresiba, diabetes, insulin degludec

Diabetes specialist firm Novo Nordisk has resubmitted its applications for two insulins to the FDA, along with new interim safety …

Novo image

Novo resubmits FDA application for two diabetes drugs

March 27, 2015
Sales and Marketing Danish, FDA, Novo Nordisk, Ryzodeg, Tresiba, diabetes

Novo Nordisk will re-submit an FDA application for its diabetes drugs Tresiba and Ryzodeg two years after their initial rejection …

Saxenda image

Novo Nordisk obesity drug shows added benefits

March 9, 2015
Sales and Marketing (liraglutide), Contrave, Novo Nordisk, Victoza, Xenical, liraglutide, obesity, saxenda, weight

New research by Novo Nordisk has suggested that its obesity drug Saxenda can help improve several other weight-related problems as …

UK pharma commits at least ‘one code breach a week’

February 18, 2015
Medical Communications, Sales and Marketing ABPI, AstraZeneca, Bayer, Eli Lilly, GSK, Novartis, Novo Nordisk, PMCPA, Pfizer, code

Pharma companies commit unethical marketing practices on average more than once a week in the UK academic analysis has found. …

Hospira image

Hospira closing US manufacturing plant

January 20, 2015
Manufacturing and Production, Sales and Marketing Clayton, Hospira, Novo Nordisk, Vancomycin hydrochloride, illinois, manufacturing

US injectable drugs specialist Hospira is to close its Clayton plant in North Carolina affecting 250 workers. Manufacturing of products …

Novo image

Novo Nordisk obesity drug gets FDA nod

December 24, 2014
Sales and Marketing FDA, Novo Nordisk, Victoza, diabetes, liraglutide, saxenda

The US Food and Drug Administration has shown Novo Nordisk’s obesity drug Saxenda the green light to aid chronic weight …

GSK image

GSK tops pharma league for access

November 17, 2014
Sales and Marketing Africa, GSK, Novo Nordisk, access, market, vaccines

GlaxoSmithKline is basking in some good news after topping the league table of pharma companies which do the most to …

Novo Nordisk to open $130 million diabetes labs

November 3, 2014
Manufacturing and Production, Sales and Marketing Denmark, Måløv, Novo Nordisk, Tresiba, Victoza, diabetes

Novo Nordisk has invested $130 million in new diabetes laboratories as the company looks to focus more strongly on the …

The Gateway to Local Adoption Series

Latest content